Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors (UROVISIO)
Primary Purpose
Hematuria, Nephrolithiasis, Cancer of Urinary Tract
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Laser confocal microscopy
Sponsored by
About this trial
This is an interventional diagnostic trial for Hematuria focused on measuring Laser Confocal Microscopy, Superior Urinary Tract Tumors
Eligibility Criteria
Inclusion Criteria:
- Any legally adult fully informed patient who consent to participate to the study
- Patient followed by the Urology Department
- Indication for a diagnosis or treatment reno-ureteroscopy
- Coverage of the social insurance
Exclusion Criteria:
- Minor Patient
- Pregnancy or breast feeding
- Concomitant treatment (for example beta-blocker)
- Contra-indication to general anaesthesia
- Hypersensitivity to sodium fluorescein
- Medical history of cardio-pulmonary disease (myocardial infarction, cardiovascular event, bronchospasm ...) due to fluorescein instillation
- Medical history of asthma or allergy due to fluorescein instillation
Sites / Locations
- Groupement des Hôpitaux de l'Institut Catholique de Lille
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Laser confocal microscopy
Arm Description
Patients undergoing a reno-ureteroscopy for diagnosis or treatment indication will follow a laser confocal microscopy procedure.
Outcomes
Primary Outcome Measures
Diagnostic relevance of laser confocal microscopy compared to the cytological and histological data, during reno-ureteroscopy according to Chang's reference criteria
According to Chang's reference criteria, we will define the urothelial microarchitecture (normal, papillary, inflammatory, low grade lesion, high grade lesion, in situ carcinoma). The diagnostic relevance of the MCL (absence or presence of the lesion) will be compare to the reference tests calculating sensibility, specificity and predictive values
Secondary Outcome Measures
Inter- and intra-observer diagnostic concordance
Anonymized videos of the intervention will be reviewed at the end of the study by a "naive" surgeon to assess inter-observer concordance. A concordance Kappa test will be performed
Surgery duration
Reference atlas
Videos and images quality will be assessed to compile them in a refence atlas
Full Information
NCT ID
NCT02276924
First Posted
August 29, 2014
Last Updated
March 19, 2019
Sponsor
Lille Catholic University
1. Study Identification
Unique Protocol Identification Number
NCT02276924
Brief Title
Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
Acronym
UROVISIO
Official Title
Diagnostic Relevance of Laser Confocal Microscopy During Reno-ureteroscopy in the Context of the Screening and Follow-up of Upper Urinary Tract Tumors
Study Type
Interventional
2. Study Status
Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
October 2013 (Actual)
Primary Completion Date
October 2016 (Actual)
Study Completion Date
October 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lille Catholic University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Upper Urinary Tract Tumors have an incidence of 1 to 2 cases for 100 000 persons per year. The standard treatment for these tumors is the ablation of the kidney, ureter and a part of the bladder surrounding the ureteral orifice. The development of new diagnosis and treatment techniques through natural routes opens the possibility to use conservative treatments. The investigators hypothesis is that during a reno-ureteroscopy, laser confocal microscopy will allow the discrimination between normal and pathologic urothelium by microscopic analysis. This will prevent the systematic use of biopsies which are often difficult and iatrogenic.
Detailed Description
The objective of the present study is to assess contribution of laser confocal microscopy in diagnosing of upper urinary tract tumors during a reno-uteroscopy compared to analysing of architectural elements (vascular characteristics, organization) and cellular (morphology, cohesion, border).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hematuria, Nephrolithiasis, Cancer of Urinary Tract, Ureteropelvic Junction Obstruction
Keywords
Laser Confocal Microscopy, Superior Urinary Tract Tumors
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
29 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Laser confocal microscopy
Arm Type
Experimental
Arm Description
Patients undergoing a reno-ureteroscopy for diagnosis or treatment indication will follow a laser confocal microscopy procedure.
Intervention Type
Device
Intervention Name(s)
Laser confocal microscopy
Other Intervention Name(s)
Cell-vizio
Intervention Description
Patients undergoing a reno-ureteroscopy for diagnosis or treatment indication will receive an intra-vesical instillation of fluorescein (0.1%) for 5 minutes, followed by the laser confocal microscopy procedure.
Primary Outcome Measure Information:
Title
Diagnostic relevance of laser confocal microscopy compared to the cytological and histological data, during reno-ureteroscopy according to Chang's reference criteria
Description
According to Chang's reference criteria, we will define the urothelial microarchitecture (normal, papillary, inflammatory, low grade lesion, high grade lesion, in situ carcinoma). The diagnostic relevance of the MCL (absence or presence of the lesion) will be compare to the reference tests calculating sensibility, specificity and predictive values
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Inter- and intra-observer diagnostic concordance
Description
Anonymized videos of the intervention will be reviewed at the end of the study by a "naive" surgeon to assess inter-observer concordance. A concordance Kappa test will be performed
Time Frame
24 months
Title
Surgery duration
Time Frame
24 months
Title
Reference atlas
Description
Videos and images quality will be assessed to compile them in a refence atlas
Time Frame
24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Any legally adult fully informed patient who consent to participate to the study
Patient followed by the Urology Department
Indication for a diagnosis or treatment reno-ureteroscopy
Coverage of the social insurance
Exclusion Criteria:
Minor Patient
Pregnancy or breast feeding
Concomitant treatment (for example beta-blocker)
Contra-indication to general anaesthesia
Hypersensitivity to sodium fluorescein
Medical history of cardio-pulmonary disease (myocardial infarction, cardiovascular event, bronchospasm ...) due to fluorescein instillation
Medical history of asthma or allergy due to fluorescein instillation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Louis Bonnal, MD
Organizational Affiliation
Groupement des Hôpitaux de l'Institut Catholique de Lille
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupement des Hôpitaux de l'Institut Catholique de Lille
City
Lille
State/Province
Nord Pas-de-Calais
ZIP/Postal Code
59000
Country
France
12. IPD Sharing Statement
Learn more about this trial
Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
We'll reach out to this number within 24 hrs